Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation.Philipp Ernst,Jenny Rinke,Georg-Nikolaus Franke,Frank Dicker,Torsten Haferlach,Thomas Ernst,Andreas HochhausLeukemia(2024)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要